FDA approves AbbVie combo hepatitis C treatment

WASHINGTON, D.C. (AP) — Patients with chronic hepatitis C have a new option for treating the liver-damaging virus, with the approval of a combination treatment developed by AbbVie.



via Health News Headlines - Yahoo News http://ift.tt/1v1u6iJ